Remove Competition Remove Government Remove Pharmaceutical research
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

Let’s dive into the current state of the pharma industry and learn more about what your team can do to stay ahead of the curve and the competition. First passing the Physician Payments Sunshine Act (PPSA), on the heels of the 2008 economic crisis, the US government has made it abundantly clear that we are in a new era of strict regulation.

Pharma 52
article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

Compensation and benefits Competitive payout but may be lower than experienced representatives : At entry-level positions, you’re generally offered a base salary, but sales incentives structures may also be implemented, which (unfortunately) can limit earning potential based on performance.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is worth mentioning that the government is the largest pharmaceutical buyer in Malaysia, responsible for more than half of the pharmaceutical purchasing value.

article thumbnail

Beating the Big C

Pharmaceutical Technology

” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone.

article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Pharma 98